Rift-lines within European regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account / / Malik Osmane.
Saved in:
| VerfasserIn: | |
|---|---|
| Place / Publishing House: | Hamburg, Germany : : Anchor Academic Publishing,, 2014. 2014 |
| Year of Publication: | 2014 |
| Language: | English |
| Online Access: | |
| Physical Description: | 1 online resource (283 pages) :; illustrations (some color) |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| id |
5001640288 |
|---|---|
| ctrlnum |
(MiAaPQ)5001640288 (Au-PeEL)EBL1640288 (CaPaEBR)ebr10856569 (OCoLC)871779662 |
| collection |
bib_alma |
| record_format |
marc |
| spelling |
Osmane, Malik, author. Rift-lines within European regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account / Malik Osmane. Hamburg, Germany : Anchor Academic Publishing, 2014. 2014 1 online resource (283 pages) : illustrations (some color) text rdacontent computer rdamedia online resource rdacarrier Includes bibliographical references. Description based on online resource; title from PDF cover (ebrary, viewed April 15, 2014). Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries. Biological products. Drugs Generic substitution. Pharmaceutical biotechnology industry. Electronic books. Print version: Osmane, Malik. Rift-lines within European regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account. Hamburg, Germany : Anchor Academic Publishing, c2014 12 pages 9783954891870 ProQuest (Firm) https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=1640288 Click to View |
| language |
English |
| format |
eBook |
| author |
Osmane, Malik, |
| spellingShingle |
Osmane, Malik, Rift-lines within European regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account / |
| author_facet |
Osmane, Malik, |
| author_variant |
m o mo |
| author_role |
VerfasserIn |
| author_sort |
Osmane, Malik, |
| title |
Rift-lines within European regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account / |
| title_full |
Rift-lines within European regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account / Malik Osmane. |
| title_fullStr |
Rift-lines within European regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account / Malik Osmane. |
| title_full_unstemmed |
Rift-lines within European regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account / Malik Osmane. |
| title_auth |
Rift-lines within European regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account / |
| title_new |
Rift-lines within European regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account / |
| title_sort |
rift-lines within european regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account / |
| publisher |
Anchor Academic Publishing, |
| publishDate |
2014 |
| physical |
1 online resource (283 pages) : illustrations (some color) |
| isbn |
9783954891870 |
| callnumber-first |
R - Medicine |
| callnumber-subject |
RS - Pharmacy |
| callnumber-label |
RS189 |
| callnumber-sort |
RS 3189 O863 42014 |
| genre |
Electronic books. |
| genre_facet |
Electronic books. |
| url |
https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=1640288 |
| illustrated |
Illustrated |
| dewey-hundreds |
500 - Science |
| dewey-tens |
570 - Life sciences; biology |
| dewey-ones |
572 - Biochemistry |
| dewey-full |
572 |
| dewey-sort |
3572 |
| dewey-raw |
572 |
| dewey-search |
572 |
| oclc_num |
871779662 |
| work_keys_str_mv |
AT osmanemalik riftlineswithineuropeanregulatoryframeworkforbiosimilarswhentakingheterogeneityandvariationduringlifecycleofthereferencebiologicandthebiosimilarintoaccount |
| status_str |
n |
| ids_txt_mv |
(MiAaPQ)5001640288 (Au-PeEL)EBL1640288 (CaPaEBR)ebr10856569 (OCoLC)871779662 |
| is_hierarchy_title |
Rift-lines within European regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account / |
| _version_ |
1792330770061197313 |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01994nam a2200421 i 4500</leader><controlfield tag="001">5001640288</controlfield><controlfield tag="003">MiAaPQ</controlfield><controlfield tag="005">20200520144314.0</controlfield><controlfield tag="006">m o d | </controlfield><controlfield tag="007">cr cnu||||||||</controlfield><controlfield tag="008">140416t20142014gw a ob 000 0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9783954891870</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9783954896875 (PDF)</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(MiAaPQ)5001640288</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(Au-PeEL)EBL1640288</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CaPaEBR)ebr10856569</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)871779662</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">MiAaPQ</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="e">pn</subfield><subfield code="c">MiAaPQ</subfield><subfield code="d">MiAaPQ</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RS189</subfield><subfield code="b">.O863 2014</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">572</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Osmane, Malik,</subfield><subfield code="e">author.</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Rift-lines within European regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account /</subfield><subfield code="c">Malik Osmane.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Hamburg, Germany :</subfield><subfield code="b">Anchor Academic Publishing,</subfield><subfield code="c">2014.</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">2014</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (283 pages) :</subfield><subfield code="b">illustrations (some color)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references.</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on online resource; title from PDF cover (ebrary, viewed April 15, 2014).</subfield></datafield><datafield tag="590" ind1=" " ind2=" "><subfield code="a">Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Biological products.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drugs</subfield><subfield code="x">Generic substitution.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pharmaceutical biotechnology industry.</subfield></datafield><datafield tag="655" ind1=" " ind2="4"><subfield code="a">Electronic books.</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="a">Osmane, Malik.</subfield><subfield code="t">Rift-lines within European regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account.</subfield><subfield code="d">Hamburg, Germany : Anchor Academic Publishing, c2014 </subfield><subfield code="h">12 pages </subfield><subfield code="z">9783954891870</subfield></datafield><datafield tag="797" ind1="2" ind2=" "><subfield code="a">ProQuest (Firm)</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=1640288</subfield><subfield code="z">Click to View</subfield></datafield></record></collection> |